About this trial
The main goal of the secondary alveolar bone grafting (SABG) for alveolar clefts is the rehabilitation of the disorganized maxilla, aiming to stabilize the maxillary foundation as a solid functional mass that would abort growth disturbance, allow for teeth eruption, and enhance their orthodontic movements.
The study evaluates the outcomes of a ( SABG) technique that utilizes the retromolar cortical shell technique to reconstruct the alveolar clefts.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients of both sexes with an age range of (eight to fifteen years), with unilateral maxillary alveolar cleft.
good oral hygiene and general good health
Disqualifiers
The evidence of clinical or radiographic signs of local maxillary pathosis or palatal fistulae.
Those patients with bilateral alveolar clefts, cleft-associated syndromes, and those with a systemic disease that would affect either bone harvest or graft healing.
A history of previous failed alveolar cleft reconstruction.
Trial design
Single group
Treatments tested in this trial
Cortical-shell graft
Procedure/SurgeryRetromolar cortical shell graft technique for SABG
Treatment groups
Trial outcomes
Primary outcomes
Horizontal bone width
The amplitude of radiographic horizontal bone width change
Secondary outcomes
Vertical bone level
The amplitude of radiographic vertical bone change
Bone density
The radiographic bone density of the consolidated graft at the site of the reconstructed cleft
Sponsors and contacts
Click on the lead sponsor to view all of their trials.